帕金森病大脑表观遗传变化的概述 帕金森病大脑
Anthony Klokkaris1, Anna Migdalska-Richards1
1Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter Medical School, University of Exeter, Exeter EX2 5DW, UK.
International journal of molecular sciences
|June 19, 2024
概括
诸如DNA甲基化和非编码RNA等表观遗传因素越来越多地与帕金森病的进展有关. 了解这些表观遗传机制为这种神经退行性疾病提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 帕金森病是一种进展性神经退行性疾病,主要影响运动功能.
- 虽然已知遗传因素,但帕金森病的许多方面仍然不清楚.
- 表观遗传机制,改变基因表达而不改变DNA序列,正在成为帕金森病的关键.
研究的目的:
- 提供帕金森病表观遗传过程的最新概述.
- 要突出DNA甲基化,DNA基甲基化,基因素修饰和帕金森病大脑中非编码RNA的作用.
- 讨论当前的研究局限性,结合遗传和表观遗传研究的好处,以及潜在的新表观遗传疗法.
主要方法:
- 审查关于表观遗传学和帕金森病的当前科学文献.
- 对表观遗传机制的分析,包括DNA甲基化,DNA基甲基化,基因素修饰和非编码RNA.
- 讨论研究方法和未来方向.
主要成果:
- 表观遗传变异在帕金森病的发展和进展中具有重要意义.
- 特定的表观遗传机制,如DNA甲基化,DNA基甲基化,基因素修饰和非编码RNA在帕金森病大脑中是相关的.
- 目前的研究面临着局限性,但将遗传学和表观遗传学研究整合起来是有前途的.
结论:
- 表观遗传因素在帕金森病的发病过程中起着至关重要的作用.
- 对表观遗传机制的进一步研究对于了解帕金森病至关重要.
- 新型表观遗传疗法具有治疗帕金森病的潜力.
关键词:
通过DNA氧甲基化.通过DNA甲基化.帕金森病是帕金森氏症的一种疾病.表观遗传疗法是一种表观遗传疗法.表观遗传学是指表观遗传学.基质子的修改 基质子的修改微RNAs 是一个微型RNA.没有编码的RNAs.更多相关视频
相关概念视频
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462


